metformin hydrochloride 1000 MG / sitagliptin phosphate 100 MG 24 HR Extended Release Oral Tablet
- RxCUI
- 2709470
- RxNorm name
- metformin hydrochloride 1000 MG / sitagliptin phosphate 100 MG 24 HR Extended Release Oral Tablet
- Display name
- metformin hydrochloride 1000 MG / sitagliptin phosphate 100 MG 24 HR Extended Release Oral Tablet
- Full name
- metformin hydrochloride 1000 MG / sitagliptin phosphate 100 MG 24 HR Extended Release Oral Tablet
- Term type
- SY
- Status
- DailyMed mapping
- Updated
- 2026-06-04 23:39:01
UNII Substances#
No records found.
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Sitagliptin and Metformin hydrochloride | SITAGLIPTIN AND METFORMIN HYDROCHLORIDE | Par Health USA, LLC | 43e3b1c9-3cbd-8dc3-e063-6394a90a10a2 | 2025-11-30 | Boxed warning, Warnings, Adverse reactions | 2709470 |
| JANUMET XR | SITAGLIPTIN AND METFORMIN HYDROCHLORIDE | Merck Sharp & Dohme LLC | 64beb3d2-3aeb-4cd5-ba11-dacf6c9a5b50 | 2025-03-25 | Boxed warning, Warnings, Adverse reactions | 2709470 |
DailyMed RxNorm Mappings#
| Set ID | RxNorm mappings | Terms | SPL version | Label | Effective |
|---|---|---|---|---|---|
| 64beb3d2-3aeb-4cd5-ba11-dacf6c9a5b50 | metFORMIN hydrochloride 1000 MG / SITagliptin phosphate 100 MG 24HR Extended Release Oral Tablet [PSN] · 24 HR metformin hydrochloride 1000 MG / sitagliptin phosphate 100 MG Extended Release Oral Tablet [SCD] · metformin hydrochloride 1000 MG / sitagliptin phosphate 100 MG 24 HR Extended Release Oral Tablet [SY] | 3 | 43 | These highlights do not include all the information needed to use JANUMET XR safely and effectively. See full prescribing information for JANUMET XR. JANUMET ® XR (sitagliptin and metformin hydrochloride extended-release) tablets, for oral use Initial U.S. Approval: 2012 | 20250325 |